Filter
2920
Text search:
supply
of
medicines
Featured
Recommendations
321
New Publications
870
Language
Document type
No document type
1457
Studies & Reports
512
Guidelines
444
Manuals
183
Strategic & Response Plan
177
Training Material
46
Fact sheets
46
Situation Updates
38
Brochures
7
Resource Platforms
4
Online Courses
4
Infographics
2
Countries / Regions
India
153
Global
119
Kenya
102
Ethiopia
91
Uganda
88
South Africa
69
Sierra Leone
67
Liberia
66
Nigeria
66
Myanmar / Burma
56
Nepal
55
Malawi
55
Zambia
51
Tanzania
51
Ghana
49
Africa
48
Bangladesh
46
Ukraine
46
Western and Central Europe
44
Syria
40
Rwanda
36
Namibia
36
Latin America and the Carribbean
34
Philippines
29
Congo, Democratic Republic of
28
Zimbabwe
28
South–East Asia Region
25
Mozambique
19
Lesotho
19
Eastern Europe
19
Asia
18
Haiti
17
Venezuela
17
Senegal
15
Guinea
14
Cambodia
14
Botswana
13
East and Southern Africa
13
Eastern Europe and Central Asia
13
Burkina Faso
12
Pakistan
12
Indonesia
12
Cameroon
11
Madagascar
11
Yemen
11
West and Central Africa
11
Russia
11
South Sudan
10
Sudan
10
Middle East and North Africa
10
Western Pacific Region
10
Eswatini/ Swaziland
9
Afghanistan
8
Somalia
7
Colombia
7
Moldova
7
Georgia
7
Lebanon
6
Thailand
6
North Macedonia
6
Vietnam
6
Benin
5
Central African Republic
5
Albania
5
Laos
5
Tajikistan
5
Iraq
4
Jordan
4
Brazil
4
Sri Lanka
4
Kyrgyzstan
4
North America
4
Mali
3
China
3
Hungary
3
Bhutan
3
Poland
3
Timor Leste/ East Timor
3
Kazakhstan
3
Jamaica
3
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Turkey
2
Chad
2
Gambia
2
Argentina
2
Peru
2
Serbia
2
Bolivia
2
Libya
2
Chile
2
Paraguay
2
Fiji
2
Palestine
2
Armenia
2
Uzbekistan
2
Turkmenistan
2
United Kingdom
2
Niger
1
Togo
1
Papua New Guinea
1
Switzerland
1
Burundi
1
Ecuador
1
Greece
1
Mexico
1
Other region
1
Solomon Islands
1
Southern Africa
1
Canada
1
Bulgaria
1
Romania
1
Iran
1
Australia
1
Gabon
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Portugal
1
Belarus
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1330
Clinical Guidelines
241
Public Health
143
Key Resources
131
Women & Child Health
127
Pharmacy & Technologies
51
Capacity Building
32
Annual Report MEDBOX
2
Toolboxes
COVID-19
244
HIV
226
TB
168
AMR
158
Pharmacy
155
Mental Health
105
Conflict
91
Caregiver
76
Ebola & Marburg
66
NTDs
64
Planetary Health
63
NCDs
59
Malaria
57
Rapid Response
43
Natural Hazards
41
Health Financing Toolbox
39
Global Health Education
38
Refugee
33
Disability
28
2.0 Rapid Response
20
Cholera
10
Polio
9
Specific Hazards
9
Zika
7
Social Ethics
4
Typhoon
1
The Infant and young child feeding counselling: an integrated course includes this Director’s guide, a Trainer’s guide and Participant’s manual. Additional tools include: Course handouts; Guidelines for follow-up after training; Supportive supervision/mentoring and monitoring and an accompanyi
...
Managing possible serious bacterial infection in young infants when referral is not feasible
recommended
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker. The guideline seeks to provide programmatic guida
...
A two-week mission was conducted by WASH and quality UHC technical experts from WHO headquarters and supported by the WHO Ethiopia Country Office (WASH and health systems teams) in July 2016, to understand how change in WASH services and quality improvements have been implemented in Ethiopia at nati
...
The Director’s guide contains all the information that the course director needs in order to plan and prepare for the course, to decide which modules and sessions will be included in the training, and to select trainers and participants, starting several months before the actual training. It conta
...
2nd. edition
The new edition has been developed to make widely available to programme managers, health care workers in endemic settings, academic researchers, and other key partners, a concise source of information on strategies for MMDP for LF. It
...
People with underlying noncommunicable diseases (NCDs) such as hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer have a high risk for developing severe and even fatal COVID-19. It is important for them to strictly follow basic protective measures and make sure th
...
More than two years since the first SARS-CoV-2 infections were reported, the COVID-19 pandemic remains an acute global emergency. In this Strategic Preparedness, Readiness and Response plan for 2022, WHO sets out a number of key strategic adjustment
...
The checklist and reference list has two parts: high-level cross-cutting content (Part A) and specific programme content (Part B). Part A applies to all countries and contains situation and response analysis, the NSP development process, the goal, targets and priority-setting
...
The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set
...
La réalisation, par le Ministère de la Santé avec l’appui de l’OMS, de la cartographie des systèmes d’approvisionnement et de distribution des médicaments et autres produits de santé en République Démocratique du Congo (RDC) répond à la nécessité d’évaluer la pertinence et la co
...
Last revised 2015.
Original Word document on: http://www.epnetwork.org/Resources/Standard%20Operating%20Procedure/Handling%20receiving%20discrepancies_SOP.doc
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Background paper 7
The Independent Panel for Pandemic Preparedness and Response
May 2021
Background paper 8
The Independent Panel for Pandemic Preparedness and Response
May 2021
: Déclaration conjointe de l’OMS et de l’UNICEF encourageant une meilleure intégration des produits pharmaceutiques sensibles à la température dans la chaîne d’approvisionnement en produits de santé dans les cas appropriés, 19 novembre 2020
